Skip to main content
. 2020 Jan 31;10:1664. doi: 10.3389/fphar.2019.01664

Figure 2.

Figure 2

Overview of regulatory exclusivities relevant to the development of new uses in Europe. Marketing authorization (MA), pediatric investigation plan (PIP), pediatric-use marketing authorization (PUMA), regulation (Reg), directive (Dir).